Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BAXANO SURGICAL, INC. (BAXS)
|
Add to portfolio |
|
|
|
| Price: |
$1.85
| | Metrics |
| OS: |
49.7
|
M
| |
-178
|
% ROE
|
| Market cap: |
$92
|
M
| |
-557
|
% ROIC
|
|
Net debt:
|
$10.1
|
M
| |
|
|
|
EV:
|
$102
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($28.5)
|
M
| |
|
|
|
EBIT
|
($31.5)
|
M
| |
|
|
| EPS |
($0.71)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| Revenues | 18.6 | 14.6 | 19.2 | 26.2 | 29.8 | 25.3 | 16.5 | 5.8 |
| Revenue growth | 27.5% | -23.9% | -26.8% | -12.3% | 17.8% | 53.6% | 183.4% | 295.6% |
| Cost of goods sold | 5.6 | 4.3 | 4.6 | 7.1 | 5.7 | 4.3 | 3.0 | 1.6 |
| Gross profit | 12.9 | 10.3 | 14.6 | 19.1 | 24.1 | 21.0 | 13.4 | 4.2 |
| Gross margin | 69.7% | 70.4% | 76.2% | 72.8% | 80.9% | 82.9% | 81.5% | 72.8% |
| Sales and marketing | 25.3 | 20.0 | 21.6 | 26.3 | 34.1 | 29.4 | 15.7 | 9.3 |
| Research and development | 6.9 | 5.5 | 5.2 | 4.2 | 6.4 | 4.1 | 3.9 | 4.2 |
| General and administrative | 8.4 | 6.2 | 5.9 | 8.6 | 7.2 | 7.1 | 3.8 | 1.2 |
| EBITA | -27.4 | -27.4 | -18.0 | -20.0 | -23.6 | -19.6 | -10.0 | -10.5 |
| EBITA margin | -147.3% | -188.3% | -94.2% | -76.5% | -79.2% | -77.4% | -60.5% | -180.1% |
| Amortization of intangibles | 0.3 | | | | | | | |
| EBIT | -27.7 | -27.4 | -18.0 | -20.0 | -23.6 | -19.6 | -10.0 | -10.5 |
| EBIT margin | -148.9% | -188.3% | -94.2% | -76.5% | -79.2% | -77.4% | -60.5% | -180.1% |
| Pre-tax income | -32.0 | -29.9 | -18.3 | -19.5 | -23.2 | -17.0 | -8.6 | -9.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -32.0 | -29.9 | -18.3 | -19.5 | -23.2 | -17.0 | -8.6 | -9.5 |
| Net margin | -172.3% | -205.1% | -95.4% | -74.7% | -77.8% | -67.3% | -52.1% | -163.1% |
| |
| Diluted EPS | ($0.85) | ($1.10) | ($0.81) | ($0.94) | ($1.13) | ($0.84) | ($1.46) | ($3.91) |
| Shares outstanding (diluted) | 37.9 | 27.3 | 22.6 | 20.7 | 20.6 | 20.3 | 5.9 | 2.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|